1. Early and Long-Term Outcomes of Endovascular Aortic Repair in Young and Low Surgical Risk Patients in the Global Registry for Endovascular Aortic Treatment
- Author
-
Franco Grego, Francesco Squizzato, Velipekka Suominen, Santi Trimarchi, Michele Piazza, and Michele Antonello
- Subjects
medicine.medical_specialty ,Time Factors ,medicine.medical_treatment ,registry ,Medicare ,Aortic repair ,Endovascular aneurysm repair ,endovascular aneurysm repair ,Blood Vessel Prosthesis Implantation ,abdominal aortic aneurysm ,Aneurysm ,Risk Factors ,medicine ,Long term outcomes ,Humans ,Radiology, Nuclear Medicine and imaging ,Registries ,Adverse effect ,risk ,Aged ,Retrospective Studies ,reintervention ,business.industry ,Endovascular Procedures ,endograft ,Middle Aged ,medicine.disease ,mortality ,United States ,Surgical risk ,Abdominal aortic aneurysm ,Blood Vessel Prosthesis ,Surgery ,Treatment Outcome ,age ,aneurysm ,Concomitant ,Cardiology and Cardiovascular Medicine ,business ,Aortic Aneurysm, Abdominal - Abstract
Purpose: To investigate early- and long-term outcomes of endovascular aneurysm repair (EVAR) for infrarenal abdominal aortic aneurysm (AAA) in young and low surgical risk patients. Methods: The global registry for endovascular aortic treatment (GREAT) was queried for all patients with AAA undergoing standard EVAR; patients were excluded if had previous AAA repair or underwent concomitant procedures. Young patients were defined if age 11) risk. Young versus older patients and low-risk versus average/high-risk patients were compared. The primary endpoints were early (30 days) major adverse events (MAEs), 5-year freedom from overall mortality, aortic-related mortality, and freedom from device-related reinterventions. Time-to-event endpoints were calculated by Kaplan–Meier curves. Results: Of 3217 included patients, 182 (6%) were Conclusion: In this real-world registry, EVAR was more often offered in cases with suitable anatomy in young and low-risk patients. Low operative risk, rather than young age alone, predicted excellent early outcomes and low 5-year mortality, aortic-related mortality, and reintervention rates.
- Published
- 2021